GNH India Pharmaceuticals Limited — Immunoglobulin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Immunoglobulin · $950.0K export value · DGFT Verified
GNH India Pharmaceuticals Limited is the #10 Indian exporter of Immunoglobulin with $950.0K in export value and 19 verified shipments. GNH India Pharmaceuticals Limited holds a 0.5% market share in Immunoglobulin exports across 4 countries. The company exports 11 pharmaceutical products worth $1.8M across 3 therapeutic categories.
GNH India Pharmaceuticals Limited — Immunoglobulin Export Profile: Buyers & Destinations
Where Does GNH India Pharmaceuticals Limited Export Immunoglobulin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $700.0K | 14 | 87.0% |
| GERMANY | $50.0K | 1 | 6.2% |
| UNITED ARAB EMIRATES | $50.0K | 1 | 6.2% |
| PHILIPPINES | $5.0K | 3 | 0.6% |
GNH India Pharmaceuticals Limited exports Immunoglobulin to 4 countries. The largest destination is COLOMBIA accounting for 87.0% of GNH India Pharmaceuticals Limited's Immunoglobulin shipments, followed by GERMANY (6.2%) and UNITED ARAB EMIRATES (6.2%). These destinations reflect GNH India Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Immunoglobulin from GNH India Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER, | COLOMBIA | $255.0K | 8 |
| TO THE ORDER | COLOMBIA | $250.0K | 5 |
| NIT 900,867,756-5, BOGOTA, CARRERA | COLOMBIA | $100.0K | 2 |
| DEPOSITO ADUANERO LOGICALL | COLOMBIA | $50.0K | 1 |
| SPERBERWEG 14 RODGAU | GERMANY | $50.0K | 1 |
GNH India Pharmaceuticals Limited supplies Immunoglobulin to 5 buyers globally. The largest buyer is TO THE ORDER, (COLOMBIA), followed by TO THE ORDER (COLOMBIA) and NIT 900,867,756-5, BOGOTA, CARRERA (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Immunoglobulin Export Value and How Much Does GNH India Pharmaceuticals Limited Contribute?
India exported $39.9M worth of Immunoglobulin through 1,841 shipments from 197 suppliers to 119 countries, serving 570 buyers globally. GNH India Pharmaceuticals Limited contributes $950.0K to this total, accounting for 0.5% of India's Immunoglobulin exports. GNH India Pharmaceuticals Limited ships Immunoglobulin to 4 countries through 5 buyers.
What Is the Average Shipment Value for GNH India Pharmaceuticals Limited's Immunoglobulin Exports?
GNH India Pharmaceuticals Limited's average Immunoglobulin shipment value is $50.0K per consignment, based on 19 shipments totaling $950.0K. The largest destination is COLOMBIA (87.0% of GNH India Pharmaceuticals Limited's Immunoglobulin exports).
How Does GNH India Pharmaceuticals Limited Compare to Other Indian Immunoglobulin Exporters?
GNH India Pharmaceuticals Limited ranks #10 among 197 Indian Immunoglobulin exporters with a 0.5% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($16.4M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($14.3M), ICHOR BIOLOGICS PRIVATE LIMITED ($1.5M). GNH India Pharmaceuticals Limited processed 19 shipments to 4 destination countries.
What Immunoglobulin Formulations Does GNH India Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| V-Immune Human Normal Immunoglobulin /5% | $200.0K | 4 |
| GLOBULIC 100ML HUMAN NORMAL IMMUNOGLOBULIN BP / 5% 5GM X 100ML, PACKING : 1S, BRAND : GLOBULIC 100ML | $150.0K | 3 |
| V Immune Human Normal Immunoglobulin 5 x5g 100ml Brand V Immune TAX INV 5514 DT 03 03 23 | $100.0K | 2 |
| GLOBULIC 100ML HUMAN NORMAL IMMUNOGLOBULIN BP /5% 5GM X 100ML(BRAND : GLOBULIC 100ML)(TAX INV.# 6280 DTD: 15- | $100.0K | 2 |
| V Immune Human Normal Immunoglobulin 5 x5g 100ml Brand V Immune TAX INV 5518 DT 16 03 23 | $50.0K | 1 |
| Immuglo 50ml Human Normal Immunoglobulinfor IV USE IP 5% /2.5gm/50ml Brand Immuglo 100ml TAX INV5590 DT02.08.202 | $50.0K | 1 |
| Globulic 100ml Human Normal Immunoglobulin BP/5% 5gm x 100ml BrandGlobulic 100mlTAX DOCUMENT 6024 DTD22.11.2023 | $50.0K | 1 |
| ANTI HUMAN THYMOCYTEIMMUNOGLOBULIN/25MG/5ML(BRAND THYMOGLOBULINE) (TAX INV.6134DTD 13-02-2024)NOS | $50.0K | 1 |
| GLOBULIC 100ML HUMAN NORMAL IMMUNOGLOBULIN BP /5% 5GM X 100ML (BRAND: GLOBULIC 100ML) (TAX INV.# 6232 DTD: 0 | $50.0K | 1 |
| RECOMBINANT ANTI RHO-D IMMUNOGLOBULIN ( TRINBELIMAB )/300MCG/1ML EXPIRY 7/25 (TAX INV.# 6186 DTD: 09-03-2024) | $1.8K | 1 |
GNH India Pharmaceuticals Limited exports 12 distinct Immunoglobulin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is V-Immune Human Normal Immunoglobulin /5% with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Immunoglobulin to Key Markets
What GNH India Pharmaceuticals Limited must comply with to export Immunoglobulin to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does GNH India Pharmaceuticals Limited Compare to Nearest Immunoglobulin Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | VIRCHOW BIOTECH PRIVATE LIMITED | $1.0M | 20 | 3 | $50.0K |
| 7 | CHANDRA BHAGAT PHARMA LIMITED | $950.0K | 19 | 2 | $50.0K |
| 10 | GNH INDIA PHARMACEUTICALS LIMITED ★ | $950.0K | 19 | 4 | $50.0K |
| 4 | LAZERHEAD LIFESCIENCES PRIVATE LIMITED | $900.0K | 18 | 1 | $50.0K |
| 11 | VIRCHOW HEALTHCARE PRIVATE LIMITED | $900.0K | 18 | 10 | $50.0K |
GNH India Pharmaceuticals Limited ranks #10 among 197 Indian Immunoglobulin exporters. Average shipment value of $50.0K compared to the market average of $202.5K. The closest competitors by value are VIRCHOW BIOTECH PRIVATE LIMITED and CHANDRA BHAGAT PHARMA LIMITED.
Which Indian Ports Ship Immunoglobulin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 542 | 29.4% |
| SAHAR AIR | 518 | 28.1% |
| Bombay Air | 210 | 11.4% |
| Bombay Air Cargo | 63 | 3.4% |
| HYDERABAD AIR | 52 | 2.8% |
| DELHI AIR CARGO ACC (INDEL4) | 47 | 2.6% |
| HYDERABAD ACC (INHYD4) | 40 | 2.2% |
| DELHI AIR | 37 | 2.0% |
About GNH India Pharmaceuticals Limited
GNH India Pharmaceuticals Limited exports 11 products worth $1.8M. Beyond Immunoglobulin, top products include Pembrolizumab, Ustekinumab, Pazopanib, Lenvatinib, Actinomycin. View the complete GNH India Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Immunoglobulin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Immunoglobulin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: GNH India Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 19 individual customs records matching GNH India Pharmaceuticals Limited exporting Immunoglobulin, covering 12 formulations to 4 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 570+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Immunoglobulin Export Data from GNH India Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for GNH India Pharmaceuticals Limited's Immunoglobulin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GNH India Pharmaceuticals Limited
Full Company Profile →
11 products · $1.8M total trade · 3 categories
Immunoglobulin Stats
Company Overview
Top Products by GNH India Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for GNH India Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Immunoglobulin. For current shipment-level data, contact TransData Nexus.